Your browser doesn't support javascript.
loading
Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.
Laloi, Louise; Billotey, Natacha Chaumard; Dumas, Pierre-Yves; Paul, Franciane; Villate, Alban; Simand, Célestine; Fornecker, Luc; Puisset, Florent; Bertoli, Sarah; Simonet, Marion Boissard; Laribi, Kamel; Houyou, Dyhia; Santagostino, Alberto; Michel, Claire; Guepin, Gabrielle Roth; Guerineau, Elodie; Tabrizi, Reza; Hunault, Mathilde; Giltat, Aurélien; Kaphan, Eléonore; Bulabois, Claude; Cartet, Elodie; Rocher, Clément; Lachenal, Florence; Morisset, Stéphane; Récher, Christian; Pigneux, Arnaud; Belhabri, Amine; Michallet, Mauricette; Michallet, Anne-Sophie.
Affiliation
  • Laloi L; Department of Pharmacy, Centre Léon Bérard, Lyon, France.
  • Billotey NC; Department of Pharmacy, Centre Léon Bérard, Lyon, France.
  • Dumas PY; Department of Hematology, University Hospital of Bordeaux, Bordeaux, France.
  • Paul F; Department of Hematology, University Hospital of Montpellier, Montpellier, France.
  • Villate A; Department of Hematology, University Hospital of Tours, Tours, France.
  • Simand C; Department of Hematology, University Hospital of Strasbourg, Strasbourg, France.
  • Fornecker L; Department of Hematology, University Hospital of Strasbourg, Strasbourg, France.
  • Puisset F; Department of Pharmacy, Institut Universitaire du Cancer Oncopole, Toulouse, France.
  • Bertoli S; Department of Hematology, Institut Universitaire du Cancer Oncopole, Toulouse, France.
  • Simonet MB; Department of Hematology, University Hospital of Besançon, Besançon, France.
  • Laribi K; Department of Hematology, Hospital of Le Mans, Le Mans, France.
  • Houyou D; Department of Clinical Research, Hospital of Troyes, Troyes, France.
  • Santagostino A; Department of Hematology, Hospital of Troyes, Troyes, France.
  • Michel C; Department of Hematology, University Hospital of Nancy, Nancy, France.
  • Guepin GR; Department of Hematology, University Hospital of Nancy, Nancy, France.
  • Guerineau E; Department of Clinical Research, Hospital of Mont de Marsan, Mont de Marsan, France.
  • Tabrizi R; Department of Hematology, Hospital of Mont de Marsan, Mont de Marsan, France.
  • Hunault M; Department of Hematology, University Hospital of Angers, Angers, France.
  • Giltat A; Department of Hematology, University Hospital of Angers, Angers, France.
  • Kaphan E; Department of Hematology, University Hospital of Grenoble, Grenoble, France.
  • Bulabois C; Department of Hematology, University Hospital of Grenoble, Grenoble, France.
  • Cartet E; Department of Pharmacy, Hospital of Bourgoin-Jallieu, Bourgoin-Jallieu, France.
  • Rocher C; Department of Hematology, Hospital of Bourgoin-Jallieu, Bourgoin-Jallieu, France.
  • Lachenal F; Department of Hematology, Hospital of Bourgoin-Jallieu, Bourgoin-Jallieu, France.
  • Morisset S; Independent Biostatistician, Pérouges, France.
  • Récher C; Department of Hematology, Institut Universitaire du Cancer Oncopole, Toulouse, France.
  • Pigneux A; Department of Hematology, University Hospital of Bordeaux, Bordeaux, France.
  • Belhabri A; Department of Hematology and Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Michallet M; Department of Hematology and Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Michallet AS; Department of Hematology and Medical Oncology, Centre Léon Bérard, Lyon, France.
Cancer Med ; 12(6): 7175-7181, 2023 03.
Article in En | MEDLINE | ID: mdl-36482507

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Cytarabine Type of study: Guideline Limits: Humans Language: En Journal: Cancer Med Year: 2023 Type: Article Affiliation country: France

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Cytarabine Type of study: Guideline Limits: Humans Language: En Journal: Cancer Med Year: 2023 Type: Article Affiliation country: France